Senate Special Committee on Aging Seeks Briefing From Mylan (MYL) Over Epipen Pricing

August 24, 2016 1:14 PM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

(Updated - August 24, 2016 1:18 PM EDT)

The U.S. Senate Special Committee on Aging seeks to brief Mylan (Nasdaq: MYL) over Epipen pricing. PDF file is below.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Corporate News, Hot Corp. News, Litigation, Trader Talk

Add Your Comment